Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 1;80(2):333-8.
doi: 10.1016/j.ijrobp.2010.01.058. Epub 2010 Jun 18.

Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group

Affiliations

Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group

Lynn Million et al. Int J Radiat Oncol Biol Phys. .

Abstract

Purpose: Postoperative radiation therapy (RT) is recommended for patients with rhabdomyosarcoma having microscopic disease. Sometimes RT dose/volume is reduced or omitted in an attempt to avoid late effects, particularly in young children. We reviewed operative bed recurrences to determine if noncompliance with RT protocol guidelines influenced local-regional control.

Methods and materials: All operative bed recurrences among 695 Group II rhabdomyosarcoma patients in Intergroup Rhabdomyosarcoma Study Group (IRS) I through IV were reviewed for deviation from RT protocol. Major/minor dose deviation was defined as >10% or 6-10% of the prescribed dose (40-60 Gy), respectively. Major/minor volume deviation was defined as tumor excluded from the RT field or treatment volume not covered by the specified margin (preoperative tumor volume and 2- to 5-cm margin), respectively. No RT was a major deviation.

Results: Forty-six of 83 (55%) patients with operative bed recurrences did not receive the intended RT (39 major and 7 minor deviations). RT omission was the most frequent RT protocol deviation (19/46, 41%), followed by dose (17/46, 37%), volume (9/46, 20%), and dose and volume deviation (1/46, 2%). Only 7 operative bed recurrences occurred in IRS IV (5% local-regional failure) with only 3 RT protocol deviations. Sixty-three (76%) patients with recurrence died of disease despite retrieval therapy, including 13 of 19 nonirradiated children.

Conclusion: Over half of the operative bed recurrences were associated with noncompliance; omission of RT was the most common protocol deviation. Three fourths of children die when local-regional disease is not controlled, emphasizing the importance of RT in Group II rhabdomyosarcoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none

Figures

Figure 1
Figure 1
The cumulative incidence of local failure for all Group II patients over 10 years.
Figure 2
Figure 2
Absolute number of operative bed recurrences is depicted in relation to compliance with RT protocol guidelines. No deviation from protocol guidelines is in dark grey and deviation from protocol deviation is in light gray. The protocol compliance is depicted for all Group II patients, subgroups, IRS trial, age, histology and site.

Similar articles

Cited by

References

    1. Smith LM, Anderson JR, Qualman S, et al. Which patients with rhabdomyosarcoma (RMS) and microscopic residual tumor (Group II) fail therapy? A report from the soft tissue sarcoma committee of the Children’s Oncology Group. J Clin Oncol. 2001;19:4058–4064. - PubMed
    1. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer. 1988;61:209–220. - PubMed
    1. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993;71:1904–1922. - PubMed
    1. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995;13:610–630. - PubMed
    1. Crist W, Anderson J, Meza JL, et al. The Intergroup Rhabdomyosarcoma Study-IV: results for patients with non-metastatic disease. J Clin Oncol. 2001;19:3091–3102. - PubMed

Publication types

MeSH terms